Genmab A/S (GNMSF) Invested Capital (2019 - 2026)

Genmab A's (GNMSF) quarterly Invested Capital came in at $5.3 billion in Q4 2025, up 37571.43% on a QoQ basis from $14.0 million in Q1 2025.

Genmab A/S (GNMSF) Invested Capital (2019 - 2026) Analysis & Trends

Genmab A (GNMSF) has 3 years of Invested Capital data on file, last reported at $5.3 billion in Q4 2025.

Quarterly Invested Capital changed N/A year-over-year to $5.3 billion in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $5.3 billion (up 37571.43% YoY) and the FY2025 annual result came in at $5.3 billion, changed N/A from the prior year.
Invested Capital advanced to $5.3 billion in Q4 2025, from $14.0 million in the prior quarter.
In the past five years, Invested Capital ranged from a high of $5.3 billion in Q4 2025 to a low of $14.0 million in Q1 2025.

Download Data